LCM
IMNM icon

Landscape Capital Management’s Immunome IMNM Stock Holding History

Landscape Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,488
Closed -$208K – 764
2026
Q1 		$208K Sell
9,488
-1,118
-11% -$24.9K 0.01% 632
2025
Q4 		$228K Buy
+10,606
New +$186K 0.02% 589

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Landscape Capital Management's IMNM Position: Q2 2026 in Review

Landscape Capital Management sold out of Immunome (IMNM) in Q2 2026, closing a stake of 9,488 shares — an estimated $208K sold.

Landscape Capital Management first reported a position in IMNM in Q4 2025 and held it in 2 quarters. The position peaked at $228K in Q4 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Landscape Capital Management reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 9,488 Immunome shares in Q2 2026, an estimated $208K.
  • Landscape Capital Management first reported a position in Immunome in Q4 2025 and held it in 2 quarters.
  • Landscape Capital Management's Immunome position peaked at $228K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.